Intra-Cellular Therapies total non-operating income/expense for the twelve months ending September 30, 2024 was $0.036B, a 105.42% increase year-over-year.
Intra-Cellular Therapies annual total non-operating income/expense for 2023 was $0.02B, a 175.8% increase from 2022.
Intra-Cellular Therapies annual total non-operating income/expense for 2022 was $0.007B, a 370.41% increase from 2021.
Intra-Cellular Therapies annual total non-operating income/expense for 2021 was $0.002B, a 62.98% decline from 2020.
Intra-Cellular Therapies Total Non-Operating Income/Expense 2013-2024 | ITCI